ARCHIVES

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

This article is from The Cancer Letter archive.

Vol. 24 No. 03 | January 23, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Dickersin Named To NCAB; Gallo To Retire; FASEB Suggests 10% Increase For NIH

January 20, 1995

Also in this 8-page issue: Amgen names PhRMA executive Rodger Currie vice president for government affairs.

April 30, 2004

Wynder Group Finds No Association Between Coffee, Pancreatic Cancer

August 19, 1983

St. Jude Offers Three Fellowships

March 2, 1984

SWOG Restarts Gynecologic Malignancies Committee.

May 16, 2008

ASCO Survey Finds Docs’ Quality Time With Patients Down, Due To Paperwork.

June 22, 2001